{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:44:14Z","timestamp":1786707854559,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s11605-007-0277-x","type":"journal-article","created":{"date-parts":[[2007,9,10]],"date-time":"2007-09-10T09:30:26Z","timestamp":1189416626000},"page":"592-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["A Prospective, Double-Blind, Multicenter, Randomized Trial Comparing Ertapenem 3 Vs \u22655 Days in Community-Acquired Intraabdominal Infection"],"prefix":"10.1016","volume":"12","author":[{"given":"Antonio","family":"Basoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Chirletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola G.","family":"D\u2019Ovidio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Doglietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano M.","family":"Giulini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Malizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Taffurelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ecari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-007-0277-x_bb0010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1086\/378702","article-title":"Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections","volume":"37","author":"Solomkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s11605-007-0277-x_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archsurg.1985.01390250011002","article-title":"Reliability of criteria for predicting persistent or recurrent sepsis","volume":"120","author":"Stone","year":"1985","journal-title":"Arch Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0020","first-page":"185","article-title":"Stratified duration of prophylactic antimicrobial treatment in emergency abdominal surgery","volume":"153","author":"Andaker","year":"1987","journal-title":"Acta Chir Scand"},{"key":"10.1007\/s11605-007-0277-x_bb0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/bjs.1800810720","article-title":"Minimal antibiotic therapy after emergency abdominal surgery: A prospective study","volume":"81","author":"Schein","year":"1994","journal-title":"Br J Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/00365549709011863","article-title":"Imipenem\/cilastatin (1.5g daily) versus meropenem (3.0g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial","volume":"29","author":"Basoli","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1007\/s11605-007-0277-x_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1179\/joc.2004.16.1.62","article-title":"Management of complicated appendicitis and comparison with other primary site of intra-abdominal infections: result of a trial comparing ertapenem versus piperacillin\u2013tazobactam","volume":"16","author":"Teppler","year":"2004","journal-title":"J Chemother"},{"key":"10.1007\/s11605-007-0277-x_bb0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/109629600321263","article-title":"Modern surgical antibiotic prophylaxis and therapy\u2014less is more","volume":"1","author":"Barie","year":"2000","journal-title":"Surg Infect"},{"key":"10.1007\/s11605-007-0277-x_bb0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jac\/35.1.139","article-title":"Meropenem versus imipenem\/cilastatin in the treatment of intra-abdominal infections","volume":"35","author":"Brismar","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s11605-007-0277-x_bb0050","first-page":"277","article-title":"Antibiotic therapy in intra-abdominal infections: a review on randomized clinical trials","volume":"6","author":"Holzheimer","year":"2001","journal-title":"Eur J Med Res"},{"issue":"11\u201312","key":"10.1007\/s11605-007-0277-x_bb0055","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00383-004-1280-x","article-title":"Minimum postoperative antibiotic duration in advanced appendicitis in children: a review","volume":"20","author":"Snelling","year":"2004","journal-title":"Pediatr Surg Int"},{"key":"10.1007\/s11605-007-0277-x_bb0060","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"key":"10.1007\/s11605-007-0277-x_bb0065","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.332.7554.1358","article-title":"What is the optimal duration of antibiotic therapy?","volume":"332","author":"Paul","year":"2006","journal-title":"BMJ"},{"key":"10.1007\/s11605-007-0277-x_bb0070","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/jac\/dkg404","article-title":"Ertapenem, the first of a new group of carbapenems","volume":"52","author":"Shah","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1007\/s11605-007-0277-x_bb0075","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1128\/AAC.44.9.2389-2394.2000","article-title":"Comparative in vitro activities of ertapenem (MK-0826) against 1,001 anaerobes isolated from human intra-abdominal infections","volume":"44","author":"Goldstein","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s11605-007-0277-x_bb0080","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.45.10.2831-2837.2001","article-title":"Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1007\/s11605-007-0277-x_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0732-8893(02)00430-3","article-title":"Ertapenem (MK-0826), a new carbapenem: comparative in vitro activity against clinically significant anaerobes","volume":"44","author":"Aldridge","year":"2002","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1007\/s11605-007-0277-x_bb0090","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.SLA.0000048551.32606.73","article-title":"Ertapenem versus piperacillin\/tazobactam in the treatment of complicated intra-abdominal infections: Results of a double-blind, randomized comparative phase III trial","volume":"237","author":"Solomkin","year":"2003","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0095","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.gassur.2005.06.015","article-title":"Efficacy and safety of Ertapenem versus Piperacillin\/Tazobactam for the treatment of intra-abdominal infections (IAI) requiring surgical intervention","volume":"10","author":"De la Pena","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijsu.2005.03.010","article-title":"Ertapenem versus ceftriaxone and metronidazole for complicated intra-abdominal infections in adults","volume":"3","author":"Navarro","year":"2005","journal-title":"Int J Surgery"},{"issue":"10","key":"10.1007\/s11605-007-0277-x_bb0105","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"key":"10.1007\/s11605-007-0277-x_bb0110","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/bjs.1800810217","article-title":"Prediction of outcome using the Mannheim Peritonitis Index in 2003 patients","volume":"81","author":"Billing","year":"1994","journal-title":"Br J Surg"},{"issue":"11","key":"10.1007\/s11605-007-0277-x_bb0115","first-page":"1532","article-title":"Prognostic scoring systems to predict outcome in peritonitis and intra-abdominal sepsis","volume":"84","author":"Bosscha","year":"1997","journal-title":"Br J Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0120","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A7, 7th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000."},{"key":"10.1007\/s11605-007-0277-x_bb0125","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A5, 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards, 2000."},{"key":"10.1007\/s11605-007-0277-x_bb0130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000658-199111000-00001","article-title":"Antibiotic treatment for surgical peritonitis","volume":"214","author":"Mosdell","year":"1991","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0135","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0002-9343(91)90361-Z","article-title":"Surgical wound infection rates by wound class, operative procedure, and patients risk index. National Nosocomial Infection Surveillance System","volume":"91","author":"Culver","year":"1991","journal-title":"Am J Med"},{"issue":"1","key":"10.1007\/s11605-007-0277-x_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-198407000-00005","article-title":"Antibiotic trials in intra-abdominal infections. A critical evaluation of study design and outcome reporting","volume":"200","author":"Solomkin","year":"1984","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/109629602762539553","article-title":"Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin\u2013tazobactam","volume":"3","author":"Teppler","year":"2002","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1007\/s11605-007-0277-x_bb0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/000313489906500201","article-title":"Ticarcillin\/clavulanate versus imipenem\/cilistatin for the treatment of infections associated with gangrenous and perforated appendicitis","volume":"65","author":"Allo","year":"1999","journal-title":"Am Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1001\/archsurg.1996.01430230075014","article-title":"Management of intra-abdominal infections: the case for intraoperative cultures and comprehensive broad-spectrum antibiotic coverage. The Canadian Intra-Abdominal Infection Study Group","volume":"131","author":"Christou","year":"1996","journal-title":"Arch Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0160","first-page":"7","article-title":"New antibiotic needed as drug resistance continue to grow","volume":"34","author":"Panasevich","year":"2004","journal-title":"The Nation\u2019s Health"},{"key":"10.1007\/s11605-007-0277-x_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00000658-199607000-00003","article-title":"Management of secondary peritonitis","volume":"224","author":"Wittman","year":"1996","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-007-0277-x_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00000658-198201001-00003","article-title":"Implications of leukocytosis and fever at conclusion of antibiotic therapy for intraabdominal sepsis","volume":"195","author":"Lennard","year":"1982","journal-title":"Ann Surg"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-007-0277-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-007-0277-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23083324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23083324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-007-0277-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:28:36Z","timestamp":1761074916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23083324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1091255X23083324"],"URL":"https:\/\/doi.org\/10.1007\/s11605-007-0277-x","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Prospective, Double-Blind, Multicenter, Randomized Trial Comparing Ertapenem 3 Vs \u22655 Days in Community-Acquired Intraabdominal Infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-007-0277-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}